Related references
Note: Only part of the references are listed.Magnetic resonance elastography for staging liver fibrosis in non-alcoholic fatty liver disease: a diagnostic accuracy systematic review and individual participant data pooled analysis
Siddharth Singh et al.
EUROPEAN RADIOLOGY (2016)
The diagnostic efficacy of quantitative liver MR imaging with diffusion-weighted, SWI, and hepato-specific contrast-enhanced sequences in staging liver fibrosis-a multiparametric approach
Diana Feier et al.
EUROPEAN RADIOLOGY (2016)
Magnetic Resonance Elastography Is Superior to Acoustic Radiation Force Impulse for the Diagnosis of Fibrosis in Patients With Biopsy-Proven Nonalcoholic Fatty Liver Disease: A Prospective Study
Jeffrey Cui et al.
HEPATOLOGY (2016)
Obeticholic acid for the treatment of primary biliary cirrhosis
Palak J. Trivedi et al.
EXPERT REVIEW OF CLINICAL PHARMACOLOGY (2016)
A 48-week randomized phase 2b study evaluating cenicriviroc versus efavirenz in treatment-naive HIV-infected adults with C-C chemokine receptor type 5-tropic virus
Melanie Thompson et al.
AIDS (2016)
Liver stiffness measurement using acoustic radiation force impulse elastography in overweight and obese patients
D. Attia et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2016)
Liver stiffness measurement using acoustic radiation force impulse elastography in hepatitis C virus-infected patients with a sustained virological response
Y. Tachi et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2016)
Magnetic Resonance Elastography for the Evaluation of Liver Fibrosis in Chronic Hepatitis B and C by Using Both Gradient-Recalled Echo and Spin-Echo Echo Planar Imaging: A Prospective Study
Yu Shi et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2016)
Pharmacokinetics, Safety, and CCR2/CCR5 Antagonist Activityof Cenicriviroc in Participants With Mild or Moderate Hepatic Impairment
E. Lefebvre et al.
CTS-CLINICAL AND TRANSLATIONAL SCIENCE (2016)
Magnetic Resonance Imaging/Elastography Is Superior to Transient Elastography for Detection of Liver Fibrosis and Fat in Nonalcoholic Fatty Liver Disease
Bachir Taouli et al.
GASTROENTEROLOGY (2016)
Transient and 2-Dimensional Shear-Wave Elastography Provide Comparable Assessment of Alcoholic Liver Fibrosis and Cirrhosis
Maja Thiele et al.
GASTROENTEROLOGY (2016)
Magnetic Resonance Elastography and Other Magnetic Resonance Imaging Techniques in Chronic Liver Disease: Current Status and Future Directions
Cher Heng Tan et al.
GUT AND LIVER (2016)
The Fontan circulation and the liver: A magnetic resonance diffusion-weighted imaging study
Djoeke Wolff et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2016)
Comparative diagnostic accuracy of hepatocyte-specific gadoxetic acid (Gd-EOB-DTPA) enhanced MR imaging and contrast enhanced CT for the detection of liver metastases: a systematic review and meta-analysis
Thomas D. Vreugdenburg et al.
INTERNATIONAL JOURNAL OF COLORECTAL DISEASE (2016)
Acoustic radiation force impulse accuracy and the impact of hepatic steatosis on liver fibrosis staging
Nicole Harris et al.
JOURNAL OF MEDICAL IMAGING AND RADIATION ONCOLOGY (2016)
Liver and Spleen Stiffness Measurements by Point Shear Wave Elastography via Acoustic Radiation Force Impulse Intraobserver and Interobserver Variability and Predictors of Variability in a US Population
Maya Balakrishnan et al.
JOURNAL OF ULTRASOUND IN MEDICINE (2016)
Dynamic Contrast-enhanced MR Imaging of Advanced Hepatocellular Carcinoma: Comparison with the Liver Parenchyma and Correlation with the Survival of Patients Receiving Systemic Therapy
Bang-Bin Chen et al.
RADIOLOGY (2016)
NON-INVASIVE EVALUATION OF LIVER FIBROSIS: 2-D SHEAR WAVE ELASTOGRAPHY, TRANSIENT ELASTOGRAPHY OR ACOUSTIC RADIATION FORCE IMPULSE IMAGING?
Coskun Ozturker et al.
ULTRASOUND IN MEDICINE AND BIOLOGY (2016)
Acoustic radiation force impulse imaging for assessing liver fibrosis in alcoholic liver disease
Anita Kiani et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2016)
New Insight into the Anti-liver Fibrosis Effect of Multitargeted Tyrosine Kinase Inhibitors: From Molecular Target to Clinical Trials
Kai Qu et al.
FRONTIERS IN PHARMACOLOGY (2016)
Mammalian Target of Rapamycin: Its Role in Early Neural Development and in Adult and Aged Brain Function
Carla Garza-Lombo et al.
FRONTIERS IN CELLULAR NEUROSCIENCE (2016)
Corona-Directed Nucleic Acid Delivery into Hepatic Stellate Cells for Liver Fibrosis Therapy
Zhengping Zhang et al.
ACS NANO (2015)
Galactose-based Thermosensitive Nanogels for Targeted Drug Delivery of lodoazomycin Arabinofuranoside (IAZA) for Theranostic Management of Hypoxic Hepatocellular Carcinoma
Stephen Quan et al.
BIOMACROMOLECULES (2015)
Fluorescent cell-traceable dexamethasone-loaded liposomes for the treatment of inflammatory liver diseases
Matthias Bartneck et al.
BIOMATERIALS (2015)
Non-invasive assessment of liver fibrosis in chronic viral hepatitis
Olga H. Orasan et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2015)
Poster Session 4: Steatohepatitis: Clinical and Therapeutic
HEPATOLOGY (2015)
Strategies and endpoints of antifibrotic drug trials: Summary and recommendations from the AASLD Emerging Trends Conference, Chicago, June 2014
Natalie J. Torok et al.
HEPATOLOGY (2015)
3D molecular MR imaging of liver fibrosis and response to rapamycin therapy in a bile duct ligation rat model
Christian T. Farrar et al.
JOURNAL OF HEPATOLOGY (2015)
EASL-ALEH Clinical Practice Guidelines: Non-invasive tests for evaluation of liver disease severity and prognosis
JOURNAL OF HEPATOLOGY (2015)
Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial
Brent A. Neuschwander-Tetri et al.
LANCET (2015)
Is it really worth adapting liver stiffness cut-offs according to AST levels?
Laurent Castera
LIVER INTERNATIONAL (2015)
Tumour exosome integrins determine organotropic metastasis
Ayuko Hoshino et al.
NATURE (2015)
Vascular adhesion protein-1 promotes liver inflammation and drives hepatic
Chris J. Weston et al.
JOURNAL OF CLINICAL INVESTIGATION (2015)
Design of a Phase 2 Clinical Trial of an ASK1 Inhibitor, GS-4997, in Patients with Diabetic Kidney Disease
Joseph H. Lin et al.
NEPHRON (2015)
Current research on the treatment of primary sclerosing cholangitis
Ahmad H. Ali et al.
INTRACTABLE & RARE DISEASES RESEARCH (2015)
Review article: the endocannabinoid system in liver disease, a potential therapeutic target
P. P. Basu et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2014)
Beyond Bile Acids: Targeting Farnesoid X Receptor (FXR) with Natural and Synthetic Ligands
Andrea Carotti et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2014)
Targeted delivery of the RGD-labeled biodegradable polymersomes loaded with the hydrophilic drug oxymatrine on cultured hepatic stellate cells and liver fibrosis in rats
Jianhong Yang et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2014)
Epidermal Growth Factor Receptor Inhibition Attenuates Liver Fibrosis and Development of Hepatocellular Carcinoma
Bryan C. Fuchs et al.
HEPATOLOGY (2014)
Parallel 8: Novel Approaches in Diagnosis and Treatment in NAFLD and NASH
HEPATOLOGY (2014)
Integrins and cadherins as therapeutic targets in fibrosis
Sandeep K. Agarwal
FRONTIERS IN PHARMACOLOGY (2014)
Multifunctional polymeric nanoparticles for oral delivery of TNF-α siRNA to macrophages
Chunbai He et al.
BIOMATERIALS (2013)
Specific gene delivery to liver sinusoidal and artery endothelial cells
Tobias Abel et al.
BLOOD (2013)
The Enhanced Liver Fibrosis (ELF) score: Normal values, influence factors and proposed cut-off values
Ralf Lichtinghagen et al.
JOURNAL OF HEPATOLOGY (2013)
Preclinical Evaluation of a Radioiodinated Fully Human Antibody for In Vivo Imaging of Vascular Adhesion Protein-1-Positive Vasculature in Inflammation
Anu Ando et al.
JOURNAL OF NUCLEAR MEDICINE (2013)
Enhanced Effectivity of an ALK5-Inhibitor after Cell-Specific Delivery to Hepatic Stellate Cells in Mice with Liver Injury
Marike Marjolijn van Beuge et al.
PLOS ONE (2013)
Regression of Fibrosis and Reversal of Cirrhosis in Rats by Galectin Inhibitors in Thioacetamide-Induced Liver Disease
Peter G. Traber et al.
PLOS ONE (2013)
The effects of sorafenib on the portal hypertensive syndrome in patients with liver cirrhosis and hepatocellular carcinoma - a pilot study
M. Pinter et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2012)
Recent Developments in Myofibroblast Biology Paradigms for Connective Tissue Remodeling
Boris Hinz et al.
AMERICAN JOURNAL OF PATHOLOGY (2012)
Functional transfer of microRNA by exosomes
Willem Stoorvogel
BLOOD (2012)
Rimonabant improves obesity but not the overall cardiovascular risk and quality of life; results from CARDIO-REDUSE (CArdiometabolic Risk reDuctIOn by Rimonabant: the Effectiveness in Daily practice and its USE)
Jolien E. J. Boesten et al.
FAMILY PRACTICE (2012)
MicroRNAs in Liver Disease
Xin Wei Wang et al.
GASTROENTEROLOGY (2012)
Effects of interferon-gamma liposomes targeted to platelet-derived growth factor receptor-beta on hepatic fibrosis in rats
Feng Li et al.
JOURNAL OF CONTROLLED RELEASE (2012)
HSC-specific inhibition of Rho-kinase reduces portal pressure in cirrhotic rats without major systemic effects
Sabine Klein et al.
JOURNAL OF HEPATOLOGY (2012)
Molecular MR imaging of liver fibrosis: A feasibility study using rat and mouse models
Miloslav Polasek et al.
JOURNAL OF HEPATOLOGY (2012)
Discovery of small molecule cancer drugs: Successes, challenges and opportunities
Swen Hoelder et al.
MOLECULAR ONCOLOGY (2012)
Beneficial effects of candesartan, an angiotensin-blocking agent, on compensated alcoholic liver fibrosis - A randomized open-label controlled study
Moon Young Kim et al.
LIVER INTERNATIONAL (2012)
Monoclonal antibodies in targeted therapy
Beata Powroznik et al.
POSTEPY HIGIENY I MEDYCYNY DOSWIADCZALNEJ (2012)
Targeted Gene Silencing of TLR4 Using Liposomal Nanoparticles for Preventing Liver Ischemia Reperfusion Injury
N. Jiang et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2011)
Nanoparticles as contrast agents for in-vivo bioimaging: current status and future perspectives
Megan A. Hahn et al.
ANALYTICAL AND BIOANALYTICAL CHEMISTRY (2011)
The Effects of Angiotensin Blocking Agents on the Progression of Liver Fibrosis in the HALT-C Trial Cohort
Barham K. Abu Dayyeh et al.
DIGESTIVE DISEASES AND SCIENCES (2011)
Mammalian Target of Rapamycin (mTOR) Inhibitors Potential Uses and a Review of Haematological Adverse Effects
Sofia Sofroniadou et al.
DRUG SAFETY (2011)
Pentoxifylline Improves Nonalcoholic Steatohepatitis: A Randomized Placebo-Controlled Trial
Claudia O. Zein et al.
HEPATOLOGY (2011)
Novel Engineered Targeted Interferon-gamma Blocks Hepatic Fibrogenesis in Mice
Ruchi Bansal et al.
HEPATOLOGY (2011)
Endocannabinoids in Liver Disease
Joseph Tam et al.
HEPATOLOGY (2011)
Evaluation of polyanion-coated biodegradable polymeric micelles as drug delivery vehicles
Yuichi Ohya et al.
JOURNAL OF CONTROLLED RELEASE (2011)
Potent antifibrotic activity of mTOR inhibitors sirolimus and everolimus but not of cyclosporine A and tacrolimus in experimental liver fibrosis
Eleonora Patsenker et al.
JOURNAL OF HEPATOLOGY (2011)
Reduction of Fibrogenesis by Selective Delivery of a Rho Kinase Inhibitor to Hepatic Stellate Cells in Mice
M. M. van Beuge et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2011)
Peptide-Modified Albumin Carrier Explored as a Novel Strategy for a Cell-Specific Delivery of Interferon Gamma To Treat Liver Fibrosis
Ruchi Barisal et al.
MOLECULAR PHARMACEUTICS (2011)
Roles of microRNA-29a in the Antifibrotic Effect of Farnesoid X Receptor in Hepatic Stellate Cells
Jiang Li et al.
MOLECULAR PHARMACOLOGY (2011)
Increased Liver Uptake and Reduced Hepatic Stellate Cell Activation with a Cell-Specific Conjugate of the Rho-kinase Inhibitor Y27632
Marike Marjolijn van Beuge et al.
PHARMACEUTICAL RESEARCH (2011)
In vivo effects of pentoxifylline on enzyme and non-enzyme antioxidant levels in rat liver after carrageenan-induced paw inflammation
Stefani Vircheva et al.
CELL BIOCHEMISTRY AND FUNCTION (2010)
Moexipril for Treatment of Primary Biliary Cirrhosis in Patients with an Incomplete Response to Ursodeoxycholic Acid
Phunchai Charatcharoenwitthaya et al.
DIGESTIVE DISEASES AND SCIENCES (2010)
Galactosylated solid lipid nanoparticles with cucurbitacin B improves the liver targetability
Wenyu Wang et al.
DRUG DELIVERY (2010)
Farglitazar Lacks Antifibrotic Activity in Patients With Chronic Hepatitis C Infection
John McHutchison et al.
GASTROENTEROLOGY (2010)
Modulation of Lysyl Oxidase-like 2 Enzymatic Activity by an Allosteric Antibody Inhibitor
Hector M. Rodriguez et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
The Fibroblast Integrin α11β1 Is Induced in a Mechanosensitive Manner Involving Activin A and Regulates Myofibroblast Differentiation
Sergio Carracedo et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Allosteric inhibition of lysyl oxidase-like-2 impedes the development of a pathologic microenvironment
Vivian Barry-Hamilton et al.
NATURE MEDICINE (2010)
Development trends for human monoclonal antibody therapeutics
Aaron L. Nelson et al.
NATURE REVIEWS DRUG DISCOVERY (2010)
The human α11 integrin promoter drives fibroblast-restricted expression in vivo and is regulated by TGF-β1 in a Smad- and Sp1-dependent manner
Ning Lu et al.
MATRIX BIOLOGY (2010)
Pioglitazone, Vitamin E, or Placebo for Nonalcoholic Steatohepatitis.
Arun J. Sanyal et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Diffusion-weighted MR Imaging of the Liver
Bachir Taouli et al.
RADIOLOGY (2010)
Hepatocellular Carcinoma: Epidemiology, Surveillance, and Diagnosis
Morris Sherman
SEMINARS IN LIVER DISEASE (2010)
Transcriptional regulation of hepatic stellate cells
Jelena Mann et al.
ADVANCED DRUG DELIVERY REVIEWS (2009)
Effects of losartan on hepatic expression of nonphagocytic NADPH oxidase and fibrogenic genes in patients with chronic hepatitis C
Jordi Colmenero et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2009)
Distinct Roles for Mammalian Target of Rapamycin Complexes in the Fibroblast Response to Transforming Growth Factor-beta
Rod A. Rahimi et al.
CANCER RESEARCH (2009)
Improved diagnostic accuracy of blood tests for severe fibrosis and cirrhosis in chronic hepatitis C
Jerome Boursier et al.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2009)
Beneficial Effects of Sorafenib on Splanchnic, Intrahepatic, and Portocollateral Circulations in Portal Hypertensive and Cirrhotic Rats
Marc Mejias et al.
HEPATOLOGY (2009)
Hepatic Recruitment of the Inflammatory Gr1+ Monocyte Subset Upon Liver Injury Promotes Hepatic Fibrosis
Karlin Raja Karlmark et al.
HEPATOLOGY (2009)
CCR2 Promotes Hepatic Fibrosis in Mice
Ekihiro Seki et al.
HEPATOLOGY (2009)
Liver biopsy: The best, not the gold standard
Pierre Bedossa et al.
JOURNAL OF HEPATOLOGY (2009)
FibroMeters: A family of blood tests for liver fibrosis with high diagnostic performance and applicability in clinical practice
P. Cales et al.
PATHOLOGIE BIOLOGIE (2009)
QUANTITATIVE VISCOELASTICITY MAPPING OF HUMAN LIVER USING SUPERSONIC SHEAR IMAGING: PRELIMINARY IN VIVO FEASABILITY STUDY
Marie Muller et al.
ULTRASOUND IN MEDICINE AND BIOLOGY (2009)
Hepatic Fibrosis: Pathogenesis, Diagnosis, and Emerging Therapies Preface
Scott L. Friedman
CLINICS IN LIVER DISEASE (2008)
MR elastography
L. Huwart et al.
GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE (2008)
Magnetic resonance elastography for the noninvasive staging of liver fibrosis
Laurent Huwart et al.
GASTROENTEROLOGY (2008)
Daily cannabis use: A novel risk factor of steatosis severity in patients with chronic hepatitis C
Christophe Hezode et al.
GASTROENTEROLOGY (2008)
Effect of hepatocyte growth factor encapsulated in targeted liposomes on liver cirrhosis
Feng Li et al.
JOURNAL OF CONTROLLED RELEASE (2008)
Angiotensin receptor blockers are superior to angiotensin-converting enzyme inhibitors in the suppression of hepatic fibrosis in a bile duct-ligated rat model
Moon Young Kim et al.
JOURNAL OF GASTROENTEROLOGY (2008)
Non-invasive evaluation of liver fibrosis using transient elastography
Laurent Castera et al.
JOURNAL OF HEPATOLOGY (2008)
Resolution of liver cirrhosis using vitamin A-coupled liposomes to deliver siRNA against a collagen-specific chaperone
Yasushi Sato et al.
NATURE BIOTECHNOLOGY (2008)
Drug-loaded nano/microbubbles for combining ultrasonography and targeted chemotherapy
Zhonggao Gao et al.
ULTRASONICS (2008)
Growth factors and cytokines in wound healing
Stephan Barrientos et al.
WOUND REPAIR AND REGENERATION (2008)
Cellular targeting of the apoptosis-inducing compound gliotoxin to fibrotic rat livers
W. I. Hagens et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2008)
Cyclic Arg-Gly-Asp peptide-labeled liposomes for targeting drug therapy of hepatic fibrosis in rats
Shi-Lin Du et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2007)
FIB-4: an inexpensive and accurate marker of fibrosis in HCV infection. comparison with liver biopsy and FibroTest
Adays Vallet-Pichard et al.
HEPATOLOGY (2007)
Targeting 15d-prostaglandin J2 to hepatic stellate cells:: Two options evaluated
Werner I. Hagens et al.
PHARMACEUTICAL RESEARCH (2007)
Hepatoprotective activity of liposomal flavonoid against arsenite-induced liver fibrosis
Ardhendu K. Mandal et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2007)
Blockade of renin-angiotensin system in antifibrotic therapy
Hitoshi Yoshiji et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2007)
Identification of fibroblast heterogeneity in the tumor microenvironment
Hikaru Sugimoto et al.
CANCER BIOLOGY & THERAPY (2006)
Regulation of peroxisome proliferator-activated receptor-γ in liver fibrosis
Liu Yang et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2006)
Naltrexone, an opioid receptor antagonist, attenuates liver fibrosis in bile duct ligated rats
M. R. Ebrahimkhani et al.
GUT (2006)
A role for serotonin (5-HT) in hepatic stellate cell function and liver fibrosis
Richard G. Ruddell et al.
AMERICAN JOURNAL OF PATHOLOGY (2006)
The antiproliferative drug doxorubicin inhibits liver fibrosis in bile duct-ligated rats and can be selectively delivered to hepatic stellate cells in vivo
R Greupink et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2006)
Galectin-3 regulates myofibroblast activation and hepatic fibrosis
NC Henderson et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Selective targeting of pentoxifylline platinum-based to hepatic stellate cells using a novel linker technology
T Gonzalo et al.
JOURNAL OF CONTROLLED RELEASE (2006)
Noninvasive measures of liver fibrosis
DC Rockey et al.
HEPATOLOGY (2006)
Involvement of the serine/threonine p70S6 kinase in TGF-β1-induced ADAM12 expression in cultured human hepatic stellate cells
H Le Pabic et al.
JOURNAL OF HEPATOLOGY (2005)
Effect of galactose density on asialoglycoprotein receptor-mediated uptake of galactosylated liposomes
C Managit et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2005)
Abnormal deposition of collagen around hepatocytes in Wilson's disease is associated with hepatocyte specific expression of lysyl oxidase and lysyl oxidase like protein-2
Z Vadasz et al.
JOURNAL OF HEPATOLOGY (2005)
Growth inhibition and apoptosis in liver myofibroblasts promoted by hepatocyte growth factor leads to resolution from liver cirrhosis
WH Kim et al.
AMERICAN JOURNAL OF PATHOLOGY (2005)
Liver fibrosis
R Bataller et al.
JOURNAL OF CLINICAL INVESTIGATION (2005)
Hsp47 a novel collagen binding serpin chaperone, autoantigen and therapeutic target
JJ Sauk et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2005)
Cetuximab monotherapy and cetuximab plus irinotecan in irinotecan-refractory metastatic colorectal cancer
D Cunningham et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
The mesenchymal α11β1 integrin attenuates PDGF-BB-stimulated chemotaxis of embryonic fibroblasts on collagens
SN Popova et al.
DEVELOPMENTAL BIOLOGY (2004)
The nuclear receptor SHP mediates inhibition of hepatic stellate cells by FXR and protects against liver fibrosis
S Fiorucci et al.
GASTROENTEROLOGY (2004)
Sampling variability of liver fibrosis in chronic hepatitis C
P Bedossa et al.
HEPATOLOGY (2003)
Normal and pathologic soft tissue remodeling:: Role of the myofibroblast, with special emphasis on liver and kidney fibrosis
A Desmoulière et al.
LABORATORY INVESTIGATION (2003)
Purification of enzymatically active human lysyl oxidase and lysyl oxidase-like protein from Escherichia coli inclusion bodies
ST Jung et al.
PROTEIN EXPRESSION AND PURIFICATION (2003)
The myofibroblast in wound healing and fibrocontractive diseases
G Gabbiani
JOURNAL OF PATHOLOGY (2003)
Progression of fibrosis in chronic hepatitis C
MG Ghany et al.
GASTROENTEROLOGY (2003)
The diverse roles of Integrins and their ligands in angiogenesis
RO Hynes et al.
COLD SPRING HARBOR SYMPOSIA ON QUANTITATIVE BIOLOGY (2002)
Targeting dexamethasone to Kupffer cells: Effects on liver inflammation and fibrosis in rats
BN Melgert et al.
HEPATOLOGY (2001)
Ligands of peroxisome proliferator-activated receptor γ modulate profibrogenic and proinflammatory actions in hepatic stellate cells
F Marra et al.
GASTROENTEROLOGY (2000)
Angiotensin II induces contraction and proliferation of human hepatic stellate cells
R Bataller et al.
GASTROENTEROLOGY (2000)
Share Paper
